258 related articles for article (PubMed ID: 19260947)
1. Clinical screening and diagnosis of diabetic polyneuropathy: the North Catalonia Diabetes Study.
Jurado J; Ybarra J; Romeo JH; Pou JM
Eur J Clin Invest; 2009 Mar; 39(3):183-9. PubMed ID: 19260947
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and impact on quality of life of peripheral neuropathy with or without neuropathic pain in type 1 and type 2 diabetic patients attending hospital outpatients clinics.
Van Acker K; Bouhassira D; De Bacquer D; Weiss S; Matthys K; Raemen H; Mathieu C; Colin IM
Diabetes Metab; 2009 Jun; 35(3):206-13. PubMed ID: 19297223
[TBL] [Abstract][Full Text] [Related]
3. [Evaluation of the four simple methods in the diagnosis of diabetic peripheral neuropathy].
Jia WP; Shen Q; Bao YQ; Lu JX; Li M; Xiang KS
Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(38):2707-10. PubMed ID: 17199983
[TBL] [Abstract][Full Text] [Related]
4. High prevalence of diabetic neuropathy in population-based patients diagnosed with type 2 diabetes in the Shanghai downtown.
Lu B; Yang Z; Wang M; Yang Z; Gong W; Yang Y; Wen J; Zhang Z; Zhao N; Zhu X; Hu R
Diabetes Res Clin Pract; 2010 Jun; 88(3):289-94. PubMed ID: 20359765
[TBL] [Abstract][Full Text] [Related]
5. Predictors of vibration perception threshold in type 2 diabetic patients with proliferative retinopathy.
Magri CJ; Calleja N; Buhagiar G; Fava S; Vassallo J
Postgrad Med J; 2011 Oct; 87(1032):658-63. PubMed ID: 21954032
[TBL] [Abstract][Full Text] [Related]
6. Pedobarography - a novel screening tool for diabetic peripheral neuropathy?
Fang F; Wang YF; Gu MY; Chen H; Wang DM; Xiao K; Yan S; Yao LL; Li N; Zhen Q; Peng YD
Eur Rev Med Pharmacol Sci; 2013 Dec; 17(23):3206-12. PubMed ID: 24338463
[TBL] [Abstract][Full Text] [Related]
7. Isolated use of vibration perception thresholds and semmes-weinstein monofilament in diagnosing diabetic polyneuropathy: "the North Catalonia diabetes study".
Jurado J; Ybarra J; Pou JM
Nurs Clin North Am; 2007 Mar; 42(1):59-66. PubMed ID: 17270590
[TBL] [Abstract][Full Text] [Related]
8. Utility of the Dipstick Micraltest II in the screening of microalbuminuria of diabetes mellitus type 2 and essential hypertension.
Cortés-Sanabria L; Martínez-Ramírez HR; Hernández JL; Rojas-Campos E; Canales-Muñoz JL; Cueto-Manzano AM
Rev Invest Clin; 2006; 58(3):190-7. PubMed ID: 16958293
[TBL] [Abstract][Full Text] [Related]
9. [Selection of risk and diagnosis in diabetic polyneuropathy. Validation of method of new systems].
Jurado J; Caula J; Pou i Torelló JM
Aten Primaria; 2006 Jun; 38(2):116-21. PubMed ID: 16828016
[TBL] [Abstract][Full Text] [Related]
10. Association between asymptomatic median mononeuropathy and diabetic polyneuropathy severity in patients with diabetes mellitus.
Stamboulis E; Voumvourakis K; Andrikopoulou A; Koutsis G; Tentolouris N; Kodounis A; Tsivgoulis G
J Neurol Sci; 2009 Mar; 278(1-2):41-3. PubMed ID: 19059612
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of chronic kidney disease in type 2 diabetes in primary health care unit of Udon Thani province, Thailand.
Narenpitak S; Narenpitak A
J Med Assoc Thai; 2008 Oct; 91(10):1505-13. PubMed ID: 18972892
[TBL] [Abstract][Full Text] [Related]
12. Cardiac autonomic neuropathy in diabetes mellitus: prevalence, risk factors and utility of corrected QT interval in the ECG for its diagnosis.
Pappachan JM; Sebastian J; Bino BC; Jayaprakash K; Vijayakumar K; Sujathan P; Adinegara LA
Postgrad Med J; 2008 Apr; 84(990):205-10. PubMed ID: 18424578
[TBL] [Abstract][Full Text] [Related]
13. Neuropad as a diagnostic tool for diabetic autonomic and sensorimotor neuropathy.
Spallone V; Morganti R; Siampli M; Fedele T; D'Amato C; Cacciotti L; Maiello MR
Diabet Med; 2009 Jul; 26(7):686-92. PubMed ID: 19573117
[TBL] [Abstract][Full Text] [Related]
14. Sleep impairment in patients with painful diabetic peripheral neuropathy.
Zelman DC; Brandenburg NA; Gore M
Clin J Pain; 2006 Oct; 22(8):681-5. PubMed ID: 16988563
[TBL] [Abstract][Full Text] [Related]
15. [A comparison of clinical effectiveness of different neuropathy scoring systems in screening asymptomatic diabetic peripheral neuropathy].
Hu H; Li H; Zheng FP; Cheng Y; Miao J; Zhang W
Zhonghua Nei Ke Za Zhi; 2012 Jan; 51(1):13-7. PubMed ID: 22490752
[TBL] [Abstract][Full Text] [Related]
16. The prevalence and associated risk factors of peripheral diabetic neuropathy in Hamedan, Iran.
Kiani J; Moghimbeigi A; Azizkhani H; Kosarifard S
Arch Iran Med; 2013 Jan; 16(1):17-9. PubMed ID: 23273229
[TBL] [Abstract][Full Text] [Related]
17. Sensitivity and specificity of a new indicator test (Neuropad) for the diagnosis of peripheral neuropathy in type 2 diabetes patients: a comparison with clinical examination and nerve conduction study.
Papanas N; Giassakis G; Papatheodorou K; Papazoglou D; Monastiriotis C; Christakidis D; Piperidou H; Maltezos E
J Diabetes Complications; 2007; 21(6):353-8. PubMed ID: 17967706
[TBL] [Abstract][Full Text] [Related]
18. [Sweat function evaluation for early diagnosis of diabetic peripheral neuropathy].
Shen J; Cao Y; Han YJ; Luo XR; Xie CH; Li JM; Xue YM
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Aug; 27(8):1210-2. PubMed ID: 17715028
[TBL] [Abstract][Full Text] [Related]
19. Validation of a novel point-of-care nerve conduction device for the detection of diabetic sensorimotor polyneuropathy.
Perkins BA; Grewal J; Ng E; Ngo M; Bril V
Diabetes Care; 2006 Sep; 29(9):2023-7. PubMed ID: 16936147
[TBL] [Abstract][Full Text] [Related]
20. Diabetic polyneuropathy in the elderly. Prevalence and risk factors in two geographic areas of Italy. Italian General Practitioner Study Group (IGPSG).
Beghi E; Monticelli ML
Acta Neurol Scand; 1997 Oct; 96(4):223-8. PubMed ID: 9325473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
